Skip to main content

Table 1 Study Characteristics

From: Transparent reporting of recruitment and informed consent approaches in clinical trials recruiting children with minor parents in sub-Saharan Africa: a secondary analysis based on a systematic review

#

Author

Country

Health condition

Intervention

Study Population size

Study population age range

1

Achonduh et al. (2012) [26]

Cameroon

Malaria

Dietary supplements (vitamin A, zinc) and antimalarials (artesunate-amodiaquine)

100

6–24 months

2

Adegbehingbe et al. (2010) [27]

Nigeria

Clubfoot

Surgical methods (Ponseti method and extensive soft tissue surgery)

105

0–adult

3

Afolabi et al. (2013) [28]

The Gambia

HIV

Vaccine

48

0–9 months

4

Aluka et al. (2013) [29]

Nigeria

Fever

Coldwater sponging, oral paracetamol

88

12–120 months

5

Amadi et al. (2002) [30]

Zambia

Diarrhoea and malnutrition (cryptosporidiosis)

Antiparasitic (nitazoxanide)

96

1–7 years

6

Arimond et al. (2017) [31]

Ghana, Malawi, Burkina Faso

Undernutrition

Dietary supplements (lipid-based)

2622, 1318, 1093, 625

0–18 months

7

Armah et al. (2010) [32]

Ghana, Kenya, Mali

Gastroenteritis (Rotavirus)

Vaccine

5468

4–12 weeks

8

Armah et al. (2013) [33]

Ghana

Gastroenteritis (Rotavirus)

Vaccine

998

0–29 days

9

Christofides et al. (2006) [34]

Ghana

Anaemia (Iron deficiency)

Dietary supplement (iron)

133

6–18 months

10

Corbett et al. (2010) [35]

Malawi

HIV

Antiretrovirals (lamivudine, stavudine, nevirapine)

18

1–13 years

11

Egere et al. (2012) [36]

The Gambia

Pneumonia (Streptococcus pneumoniae)

Vaccine

328

2–30 months

12

Gilliams et al. (2014) [37]

Malawi

Malaria

Antimalarials (chloroquine-azithromycin)

320

20–46 months

13

Goodhew et al. (2014) [38]

Tanzania

Trachoma

Mass drug administration (azithromycin)

264

1–6 years

14

Hassall et al. (2015) [39]

Kenya

Malaria

Umbilical cord red blood cell transfusion

55

0–6 years

15

Hess et al. (2015) [40]

Burkina Faso

Undernutrition (Growth stunting)

Dietary supplements (lipid-based)

3220

9 months

16

Hesseling et al. (2005) [41]

Malawi

Burkitt Lymphoma

Chemotherapy (vincristine, methotrexate, leucovorin, cyclophosphamide, prednisone)

60

3–16 years

17

Hussey et al. (1990) [42]

South Africa

Measles

Dietary supplement (vitamin A)

189

0–13 years

18

Isanaka (2017) [43]

Niger

Gastroenteritis (Rotavirus)

Vaccine

3508

6–14 weeks

19

Kone et al. (2010) [44]

Mali

Malaria (Glucose-6-phosphate dehydrogenase deficiency)

Antimalarials (artemether-lumefantrine, artesunate-mefloquine)

315

> 1 year

20

Koram et al. (2005) [45]

Ghana

Malaria

Antimalarials (amodiaquine-artesunate, artemether-lumefantrine, sulfadoxine-pyrimethamine, chloroquine)

168

6–59 months

21

Madhi et al. (2011) [46]

South Africa

Childhood diseases (Hepatitis B, diphtheria, tetanus, pertussis, polio, Haemophilus influaenzae)

Vaccines

715

0–3 days

22

Madhi et al. (2012) [47]

South Africa, Malawi

Gastroenteritis (Rotavirus)

Vaccine

3168

6–16 weeks

23

Maka et al. (2015) [48]

Cameroon

Malaria

Antimalarials (artesunate, quinine)

238

3 months–15 years

24

Mangani et al. (2015) [49]

Malawi

Undernutrition (Growth stunting)

Dietary supplements (lipid-based, corn-soy blend)

840

5.5–6.5 months

25

Meremikwu et al. (2006) [50]

Nigeria

Malaria

Antimalarials (artemether-lumefantrine, artesunate-amodiaquine)

119

6–59 months

26

Meremikwu et al. (2016) [51]

Nigeria

Malaria

Antimalarials (artesunate-amodiaquine, dihydroartemisinin-piperaquine, artemether-lumefantrine)

493

6–59 months

27

Michael et al. (2010) [52]

Nigeria

Malaria

Antimalarials (artemether-lumefantrine, artesunate-amodiaquine)

193

12–132 months

28

Ngasala et al. (2011) [53]

Tanzania

Malaria

Antimalarials (artemether-lumefantrine)

300

3–59 months

29

Nji et al. (2015) [54]

Cameroon

Malaria

Antimalarials (dihydroartemisin-piperaquine, artesunate-amodiaquine vs artemether-lumefantrine)

720

6 months–10 years

30

Nwanyanwu et al. (1996) [55]

Malawi

Malaria

Antimalarials (sulphadoxine-pyrimethamine)

159

0–5 years

31

Phuka et al. (2008) [56]

Malawi

Undernutrition (Growth stunting)

Dietary supplements (fortified spread, micronutrient-fortified maize-soy flour)

182

6–18 months

32

Rahimy et al. (1999) [57]

Benin

Fever (in Sickle Cell Disease)

Antibiotics (outpatient management)

61

0–12 years

33

Robertson et al. (2011) [58]

Uganda

Perinatal asphyxial encephalopathy

Therapeutic hypothermia

36

3 h

34

Roca et al. (2011) [59]

The Gambia

Pneumococcal disease

Vaccine

5441

0–adult

35

Sazawal et al. (2007) [60]

Zanzibar

Undernutrition (Mortality)

Dietary supplement (zinc)

42,546

1–36 months

36

Schellenberg et al. (2001) [61]

Tanzania

Malaria and anaemia

Antimalarials (sulphadoxine-pyrimethamine) alongside routine vaccinations

701

0–1 year

37

Singana et al. (2016) [62]

Republic of Congo

Malaria

Antimalarials (artesunate-amodiaquine, artemether-lumefantrine)

198

< 12 years

38

Sissoko et al. (2016) [63]

Guinea

Ebola

Antiviral (favipiravir)

111

> 1 year

39

Sow et al. (2012) [64]

Mali

Gastroenteritis (Rotavirus)

Vaccine

1960

48 days (median age)

40

Te Water Naude et al. (2000) [65]

South Africa

Tuberculosis

Chemotherapy (isoniazid, rifampin, pyrazinamide)

206

0–14 years

41

The Zinc Against Plasmodium Study Group (2002) [66]

Ecuador, Ghana, Tanzania, Uganda, Zambia

Malaria

Antimalarial and dietary supplement (chloroquine and zinc)

1087

6–60 months

42

Urban et al. (2008) [67]

South Africa

Nutrition (Infant growth)

Dietary supplements (biologically acidified milk, probiotics)

85

0–1 week

43

Waggie et al. (2011) [68]

South Africa

Polio

Vaccine

800

0–30 days

44

Yohannan et al. (2013) [69]

Tanzania

Trachoma

Mass drug administration (azithromycin, tetracycline)

2261

0–5 years